Cardiovascular disease in SARS‐CoV‐2 infection

Clinical & Translational Immunology, 2021, Vol.10 (9), p.e1343-n/a [Peer Reviewed Journal]

2021 The Authors. published by John Wiley & Sons Australia, Ltd on behalf of Australian and New Zealand Society for Immunology, Inc ;2021 The Authors. Clinical & Translational Immunology published by John Wiley & Sons Australia, Ltd on behalf of Australian and New Zealand Society for Immunology, Inc. ;2021. This work is published under http://creativecommons.org/licenses/by-nc/4.0 (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2021. This work is published under http://creativecommons.org/licenses/by-nc/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 2050-0068 ;EISSN: 2050-0068 ;DOI: 10.1002/cti2.1343 ;PMID: 34512975

Digital Resources/Online E-Resources